What You Should Know:
– Panacea, the genetic health services provider, announces nationwide commercial availability, enabling consumers to access potentially life-saving testing without doctor visits or insurance approval.
– Offering whole exome sequencing, Panacea conducts in-depth analysis of every human gene, aiding in the identification of disease-driving mutations for proactive disease management.
– With nearly half of Americans facing cancer risk, approximately 20 million individuals could benefit from comprehensive genetic testing, yet current guidelines and insurance coverage overlook many, with costs reaching over $10,000 even when covered.
